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Xeroderma pigmentosum (XP) and Cockayne syndrome (CS) are both rare autosomal recessive disorders with
defects in DNA repair. They are usually distinct both clinically and genetically but in rare cases, patients exhibit the
clinical characteristics of both diseases concurrently. We report two new phenotypically distinct cases of XP with
additional features of CS (xeroderma pigmentosum and Cockayne syndrome crossover syndrome (XP/CS)) car-
rying an identical mutation (G47R) in the XPD gene within the N terminus of the protein. Both patients had clinical
features of XP and CS but only one fulﬁlled most criteria for diagnosing CS. Unusually, patient 1 developed early
skin cancer, in contrast to patient 2, who never developed any malignancies. Cells from both these patients have
repair defects typical of xeroderma pigmentosum complementation group D (XPD) cells, but also had the phe-
notype of uncontrolled DNA breakage found specifically in XPD/CS cells and similarly reduced levels of TFIIH.
Despite these similarities between our two patients, their clinical features are quite different and the clinical
severity correlates with other cellular responses to ultraviolet irradiation.
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Various agents including ultraviolet (UV) radiation and reac-
tive oxygen species damage DNA. In order to survive this
damage, cells have developed several mechanisms with
which the DNA damage can be repaired. Nucleotide exci-
sion repair (NER) is the process primarily responsible for the
removal of the main UV photoproducts, cyclobutane pyrimi-
dine dimers and 6-4 photoproducts (Friedberg et al, 1995;
De Boer and Hoeijmakers, 2000). There are two forms of
NER: global genome repair (GGR) and transcription coupled
repair (TCR). The latter is a rapid process for the preferential
repair of the transcribed strands of active genes. The rare
autosomal recessive disorders xeroderma pigmentosum
(XP), Cockayne syndrome (CS), and trichothiodystrophy
(TTD) all result from impaired or absent NER (De Boer and
Hoeijmakers, 2000).
XP patients are characterized by photosensitivity, pho-
todamage, and pigmentation, the early development of cu-
taneous malignancies, and opthalmological complications
(Robbins et al, 1974). Neurological problems occur in ap-
proximately 20% of patients with XP and can be severe
(Kraemer et al, 1987). This is thought to be because of
primary axonal degeneration (Robbins et al, 1991). Life
expectancy in XP patients is reduced often because of
cutaneous malignancies or neurological deterioration. XP is
caused, in most cases, by a defect in NER of photo-induced
DNA damage. Mutations in several different genes result in
seven complementation groups in XP (XPA–XPG) (De Boer
and Hoeijmakers, 2000), in addition to a variant group de-
ficient in translesion synthesis (Lehmann et al, 1975; Mas-
utani et al, 1999). Neurological features are predominantly
associated with complementation groups A, D, and G (Leh-
mann, 2003).
CS is characterized by growth failure, severe and pro-
gressive neurological deterioration, cachexia, retinal de-
generation, and photosensitivity (Cockayne, 1936; Neill and
Dingwall, 1950). Other features include cataracts, bilateral
sensorineural deafness, skeletal abnormalities, micro-
cephaly, intracranial calcification, and dental caries (Nance
and Berry, 1992). These patients appear prematurely aged
with bird-like facies, prominent nose, sunken eyes, and loss
of subcutaneous fat. They do not develop cutaneous ma-
lignancies or pigmentation changes associated with XP
(Nance and Berry, 1992). In CS, the neurological abnormal-
ities are because of dysmyelination (Soffer et al, 1979). Mu-
tations are found in two genes, CSA (chromosome 5)
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(Henning et al, 1995) or more frequently, CSB (chromosome
10) (Troelstra et al, 1993; Mallery et al, 1998), and cause
defective transcription-coupled repair of UV damage (van
Hoffen et al, 1993). There may also be subtle transcription
defects (Balajee et al, 1997; van Gool et al, 1997; Tantin,
1998), and there is evidence for defective TCR of oxidative
damage (Le Page et al, 2000).
The XPD and XPB proteins are subunits of the basal
transcription factor TFIIH complex, which has several func-
tions including NER, basal transcription by both RNA po-
lymerases I and II, and activated transcription (Egly, 2001;
Lehmann, 2001). Mutations in the XPD gene can result in
several different clinical phenotypes, the most common of
which are XP or TTD. Much less frequently seen are the
combined features of XP and CS (Broughton et al, 1995;
Takayama et al, 1995), XP and TTD (Broughton et al, 2001),
or cranio-oculo-facial syndrome (COFS) (Graham et al,
2001). In general, each mutational change is specific for a
particular clinical phenotype (Taylor et al, 1997).
Although there are several reports in the literature of pa-
tients with the combined features of xeroderma pigmento-
sum and Cockayne syndrome crossover syndrome (XP/CS)
(Rapin et al, 2000), only two of these fall into the XPD
complementation group (Lafforet and Dupuy, 1978; Brough-
ton et al, 1995; Takayama et al, 1995). XP8BR and XP-CS-2,
the cell lines derived from these patients, respectively, carry
the mutations G675R and G602D in the C-terminal third of
the XPD protein (Broughton et al, 1995; Takayama et al,
1995). We now report two further patients with clinical and
cellular features of XP/CS. They have an identical mutation
in the XPD gene, located within the ATPase domain, close
to the N-terminus of the protein, and show the breakdown
of cellular DNA following UV-irradiation that we previously
reported as a specific feature of the other two XPD/CS
cases. Despite similar molecular and cellular characteris-
tics, these two new patients differ substantially in clinical
features.
Discussion
XP, CS, and TTD are all rare inherited disorders of DNA
repair. XPD mutations have been identified in patients with
each of XP, TTD, XP/CS, XP with features of TTD and COFS.
The XPD gene is particularly complex (Lehmann, 2001),
because XPD is a subunit of TFIIH, which has functions in
NER, basal transcription by RNA polymerases I and II, and
transcriptional activation (Keriel et al, 2002).
The XP/CS crossover syndrome has also been reported
with mutations in both XPB and XPG (Vermeulen et al, 1993;
Emmert et al, 2000). In general, the sites of mutation within
the XPD gene are specific for one or other of the clinical
phenotypes (Taylor et al, 1997). Mutations affecting NER
alone cause XP, whereas if transcription is also affected,
TTD results (Lehmann, 2001).
Fibroblasts from XP/CS patients are exquisitely sensitive
to UV-induced killing but the repair defect appears similar to
that of XPD (Broughton et al, 1995). During NER in normal
cells, after UV exposure, breaks are generated transiently in
the DNA near the damaged sites. Such NER-dependent
breaks are not observed in XP cells. In XP/CS cells, how-
ever, breaks are observed randomly in DNA following UV
irradiation but not at the sites of damage (Berneburg et al,
2000). These breaks are likely to be responsible for the ex-
treme sensitivity of XP/CS cells to UV killing.
In this report, we have identified two further patients with
this complex XP/CS phenotype. Cells from both patients
showed breaks in cellular DNA following UV irradiation, ob-
served specifically in the two previously reported cases of
XPD/CS. The cellular responses of both patients also dem-
onstrated reduced cell survival after UV irradiation com-
pared with normal (much more marked in XP1J1), and
similarly reduced RNA synthesis recovery and TFIIH levels.
But, clinically, patient 1 (XP1JI) had features clearly con-
sistent with a diagnosis of both XP and CS, whereas patient
2 (XP1NE) was more typical of XP with neurological disease
although she had several features consistent with CS
(progeroid changes, bird-like facies, skeletal abnormalities,
dental caries, and sclerodermatous changes to her skin).
This patient was also most unusual in not developing any
cutaneous malignancies. CS patients do not develop ma-
lignancies. Yet, ocular features typical of CS were absent.
Although diagnosed with XP at age 22, in retrospect, taking
into consideration the identical mutant allele and similar
in vitro findings with XPD/CS specific breakage in DNA in
both patients, we feel that this patient may represent an
unusual case of the XP/CS phenotype.
The two previously reported XPD/CS patients had mu-
tations in the C terminal third of the XPD protein (Broughton
et al, 1995; Takayama et al, 1995). This part of the protein is
involved in the interaction with the p44 subunit of TFIIH
(Coin et al, 1998) that stimulates helicase activity of XPD
within the TFIIH complex. Our current patients are both
compound heterozygous for mutation G47R close to the N-
terminus of the XPD protein. Glycine-47 is part of the Walker
A nucleotide-binding sequence GXGKS/T found in many
ATP-binding proteins and ATP-dependent helicases. This
mutation abolishes both ATPase and DNA helicase activity
of the XPD protein and results in deficient NER both in vivo
(Fig 3a) and in vitro (Dubaele et al, 2003), accounting for the
XP phenotype. A mutation generated in the neighboring
base K48R also abolished ATPase and NER activity, but had
no effect on the transcriptional activity of TFIIH (Winkler
et al, 2000). G47R found in our patients resulted in similarly
reduced levels of TFIIH (63% decrease in transcriptional
activity of TFIIH in vitro), and may account for their CS fea-
tures (Dubaele et al, 2003).
We only identified a mutation on one allele of XP1JI and
assume the other allele is not expressed. XP1NE, however,
had two other mutations on the second allele: L461V and
del 716–730 (Taylor et al, 1997). The deletion is thought to
render the XPD protein inactive, resulting in a null allele
(Taylor et al, 1997). It abolishes helicase, NER activity, and
transcriptional activity of TFIIH and is only ever found in one
allele in compound heterozygotes, never as a homozygous
mutation. Thus, both patients were functionally hemizygous
for the G47R mutation, and showed cellular and clinical
features of XP/CS patients. The two previously reported
XPD/CS patients were also functionally hemizygous, with
the second allele either not expressed (XP-CS-2) (Takayama
et al, 1995) or non-functional (XP8BR) (Broughton et al,
1995). As with the current patients, the mutation in the
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The DNA breakage assay was performed as previously de-
scribed (Berneburg et al, 2000). In brief, cells were trypsinized and
embedded in agarose on microscope slides. Immediately following
irradiation, cells were incubated at 371C in the dark with 100 mM
AraC and 10 mM HU (Sigma-Genosys, Suffolk, UK) to allow inci-
sions to accumulate. Slides were subsequently immersed in a lysis
solution for at least 1 h at 41C and electrophoresed in alkaline
conditions. Slides were washed in neutralizing buffer and stained
with ethidium bromide solution. Comet lengths were measured
using the Casys system (Synoptics, Cambridge, UK) and comet
tail moments were measured using the Comet Assay III software
(Perceptive Instruments, Suffolk, UK).
Clinical investigations
Patient 1 Patient 1 (Fig 1) was the son of non-consanguineous
Japanese parents. At birth he was of normal weight. The only ab-
normalities noted were clenched hands with overlapping of the
fingers and bilateral rocker-bottom feet (Fig 1a). There were no
chromosomal abnormalities. At 2 mo of age, moderate dermatitis
on the face was noted after short sun exposure. At 3 mo, the
following were low: weight; 4190 g (2.5 SD), length; 53 cm (2.3
SD), and head circumference; 35.0 cm (2.5 SD). He subsequently
developed growth failure and almost complete absence of motor
and mental development.
At 1 y and 10 mo, a diagnosis of CS was made. His weight was
6350 g (4.1 SD), height; 70.5 cm (4.8 SD), and head circum-
ference; 37.5 cm (5.9 SD). His nose was prominent, he had
widespread dental caries, mild cataracts, atypical retinal pigmen-
tary degeneration, bilateral optic atrophy, a small scrotum, and
impalpable testes.
A computed tomography (CT) scan showed marked dilatation
of the lateral and fourth ventricles and bilateral basal ganglia cal-
cification (Fig 1b). Magnetic resonance imaging (MRI) of the brain
showed hypoplasia of the brain stem and cerebellar vermis. De-
layed myelination was not evident (this may be because of the
young age of the patient). Peripheral motor nerve conduction ve-
locities showed delayed conduction suggesting demyelination.
Slight sensorineural hearing loss was suggested by the condi-
tioned orientation reflex (COR) test (40 dB loss at 500 Hz and 30 dB
loss above 1000 Hz) and confirmed by the brain-stem auditory-
evoked responses (ABR) test. All the above features are charac-
teristic of CS. He, however, also demonstrated pigmentation of
sun-exposed skin and freckling characteristic of XP (Fig 1c) evident
at approximately 6 mo of age. Taken together, these features sug-
gested a combination of XP/CS.
Subsequently, he developed liver dysfunction and progressive
thrombocytopenia (possibly virally induced). A rapidly growing
nodule was noted above the left eyebrow (Fig 1d). This was treated
unsuccessfully with cryosurgery, and subsequently increased to 1
cm in diameter and ulcerated. Histology confirmed that the lesion
was a squamous cell carcinoma. The patient died aged 2 y and
4 mo with severe liver dysfunction.
Patient 2 Patient 2 was the daughter of non-consanguineous Cau-
casian English parents weighing 2325 g. No abnormalities were
noted at birth except bilateral pes cavus. But during childhood, she
remained below the third percentile for height and weight. Men-
struation occurred at age 15 but was always sparse and irregular. A
long-standing history of severe photosensitivity was noted with
increasing pigmentation of sun-exposed skin from an early age.
She was diagnosed with XPD aged 22 y (Lehmann and Stevens,
1980). There was no family history.
Intellectual development appeared normal until early adoles-
cence when ability deteriorated markedly. At age 12, her IQ was
64, at 15 y it was 53. Further neurological problems were initially
detected aged 26 y when she was noted to have an unsteady gait.
Neurological deterioration continued with marked cerebellar signs
and she became wheelchair bound by 35 y. She was dysarthric,
with profound bilateral sensorineural hearing loss. Insulin-depend-
ent diabetes was diagnosed aged 32 y.
Her condition continued to deteriorate and she died aged 43 y
from sepsis because of severe cystitis and bilateral pyelonephritis.
Physical findings aged 37 y demonstrated a cachectic female of
short stature (height 132 cm, weight 30 kg) who appeared prema-
turely aged with sunken eyes, beaked nose, and sparse hair (Fig
2a). Her skin was pigmented, dry, and freckled all over, most
marked on sun-exposed sites. She had tight, perniotic-looking
skin over the digits (Fig 2b). Several keratotic skin lesions were
noted but no skin malignancies. She had minimal secondary
sexual characteristics. Ophthalmological examination was normal.
Marked dental caries was present.
Lymphocytes showed a normal 46XX karyotype with an unu-
sually high degree of chromosomal instability. Cytogenetic studies
carried out on skin biopsies showed many chromosomal rear-
rangements.
Routine investigations showed a mild leucopenia (3.9  109 per
liter) with subsequently progressive lymphopenia and thrombocy-
topenia.
X-rays demonstrated microcephaly, a thickened skull vault, and
multiple other skeletal anomalies including high iliac angles, v-
shaped wrist joints because of long ulna, bilateral coxa valga, and
fusion of lunate and triquetrium.
Neurological investigations included a polyrhythmic unstable
electroencephalogram without localizing features. Nerve conduc-
tion studies showed a mild mixed motor and sensory neuropathy,
Figure2
Clinical features of patient 2 (XPINE). (a) Patient 2 (XP1NE) face
showing freckling, hyperpigmentation and actinic keratoses, beaking of
nose, and shrunken eyes. (b) Freckling of sun exposedhands with
sclerodactyly changes affecting fingers. XP, xeroderma pigmentosum.
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audiometry revealed bilateral sensorineural hearing loss across all
frequencies. A CT brain scan showed prominent cerebral and cer-
ebellar sulci and ventricular enlargement affecting the 4th ventricle
predominantly. The cerebellum showed a low-density vermis.
There was no calcification. MRI was not available at this time.
Phototesting revealed increased sensitivity to UVA and UVB,
maximal at 300–320 nm and still present at 72 h.
This patient therefore has features that would fit with XPD neu-
rological disease but unusually did not develop any malignancies.
Some other features, especially the facies, skeletal abnormalities,
lack of secondary sexual characteristics, dental caries, and pro-
gerioid changes support a diagnosis of XP/CS overlap but this
unfortunately cannot be confirmed absolutely from a clinical point
of view.
Cellular responses to UVC irradiation Fibroblast cultures were
established from patients 1 and 2 and designated XP1JI and
XP1NE, respectively. The DNA repair status of XP1NE has been
reported in several studies in the literature. UDS was about 40% of
normal (Lehmann and Stevens, 1980) and at that time she was
diagnosed as XP. Cell fusion studies assigned the patient to
complementation group D (Lehmann and Stevens, 1980). Cell sur-
vival studies showed marked sensitivity to killing by UVC irradiation
(Taylor et al, 1997). Similar studies with XP1JI showed an even
greater sensitivity to UV-induced cell killing, similar to that of the
previously characterized XP/CS cell strains XP8BR and XP-CS-2
(Fig 3a).
The response of RNA synthesis to UV irradiation (an assay we
have found to be a useful measure of UV sensitivity) was meas-
ured: both cell strains showed very defective responses, slightly
more marked in XP1JI than in XP1NE (Fig 3b). The response of
XP1DU cells from an XPD patient with XP is shown for comparison.
The UDS level in XP1JI was 30%–45% of normal, similar to that in
XP1NE (Fig 3c). Complementation analysis was carried out using a
host-cell reactivation assay, in which cells were cotransfected with
a UV-irradiated plasmid expressing the CAT gene, together with
undamaged pcDNA3 plasmids expressing different XP cDNA
(Fig 3d). CATactivity was very low if the cotransfecting plasmid was
the empty pcDNA3 vector, or pcDNA3 expressing the XPA, B, C, F,
or G cDNA. In contrast, the CAT activity was more than 10 times
greater if the cotransfecting plasmid expressed the XPD cDNA.
Thus, only the XPD gene was able to restore repair activity to XP1JI
and we therefore assign XP1JI to the XPD complementation group.
Mutational analysis Sequencing analysis of the XPD cDNA in
XP1NE showed a compound heterozygote for G47R in one allele,
and L461V together with del 716–730 in the second allele (Taylor
et al, 1997). The latter are always found together and result in a
non-functional protein, and is therefore considered a null allele





















































































Cellular responses of XP1JI to ultraviolet (UV) C. (a) UV survival. Normal or XP1JI cells were UV irradiated and plated to form colonies after
suitable dilution. Data for XP1NE and XP8BR are taken from Taylor et al (1997) and Broughton et al (2001). (b) RNA synthesis. Serum-starved cells
were UV irradiated with the indicated doses, incubated for 24 h, and then labelled with 3H-uridine to measure RNA synthesis. Means  SEM of two
to four experiments are shown including XP1DU from an xeroderma pigmentosum (XP) complementation group D (XPD) patient with xeroderma
pigmentosum (XP). (c) Unscheduled DNA synthesis (UDS). Serum-starved cells were UV irradiated, and incubated for 2 h in the presence of
hydroxyurea and 3H-thymidine to measure the amount of repair synthesis. 48BR and SF are normal cells. (d) Complementation analysis. Cells were
cotransfected with the UV irradiated chloramphenicol acetyltranferase (CAT) plasmid together with pcDNA3 containing the indicated cDNA. After
incubation for 48 h, the CAT activity was measured.
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single species containing the same G47R mutation as found in
XP1NE. on analysis of genomic DNA, however, we found that this
mutation was heterozygous. The genomic DNA of both parents
demonstrated the (heterozygous) mutation only in the maternal
DNA. To confirm these results we amplified the genomic DNA
around the mutation and digested the 129 bp PCR product with
MvaI, which generates two fragments of 92 and 37 bp from the
normal sequence. But, the mutation generates an extra MvaI site
(CCAGG) resulting in fragments of 72, 37, and 20 bp from mutant
DNA. Figure 4a shows both 92 and 72 bp bands using DNA from
the proband (lanes 4, 5) and his mother (lanes 8, 9), whereas only
the 92 bp band was obtained from the DNA of the father (lanes 6,
7), and a normal control (lanes 1, 2) consistent with the sequencing
data. (The two smaller bands are not resolved.) We conclude that
XP1JI is also a compound heterozygote with G47R in the maternal
allele and a mutation in the paternal allele that prevents expression
of the XPD gene. Thus, both patients appear to be functionally
hemizygous for the G47R mutation.
Uncontrolled incisions Following UV irradiation, if repair synthe-
sis is inhibited, breaks accumulate in normal cells as intermediates
in NER. Such breaks are not found in NER-defective XP cells. In
earlier work we found that when the previously reported XPD/CS
cell strains, XP8BR and XP-CS-2, were exposed to UV-irradiation,
uniquely they did generate incisions in their DNA, despite being
NER-defective. These breaks were not, however, at the sites of
damage. They were seen even in the genomic DNA of unirradiated
cells if an irradiated plasmid was introduced into the cells. This
phenomenon was not observed in any other cell strains. We used
the comet (single cell gel electrophoresis) assay as previously de-
scribed (Berneburg et al, 2000) to analyze both the current cell
strains for UV-induced breaks. Undamaged DNA remains in the
nucleus, whereas DNA containing breaks streams out of the nu-
cleus in the electric field and is visualized as a ‘‘comet tail’’. The tail
moment gives a measure of the amount of DNA breakage. As seen
in Fig 4b, under these conditions, as expected, normal 1BR3 cells
show breaks resulting from NER, whereas NER-deficient XP1BR
cells have very few breaks. With both XP1JI and XP1NE, we ob-
served substantial breakage, induced at a level similar to that in
XP8BR cells used in our earlier studies (Berneburg et al, 2000).
These results are consistent with the diagnosis of XP/CS in XP1JI,
and raise the possibility that XP1NE, initially diagnosed clinically as
XP, may also have the combined features of XP and CS.
TFIIH levels Mutations in the XPD gene can cause destabilization
of the TFIIH complex, resulting in reduced levels of TFIIH in XPD
cells (Botta et al, 2002). This is particularly marked in TTD cells but
was also observed previously in XP1NE cells (Botta et al, 2002).
Figure 4c shows that the levels of three components of TFIIH ex-
amined, namely cdk7, p44, and p62, are reduced to similar extents
in XP1NE and XP1JI fibroblasts (about 30%–35% of normal for
cdk7, 60% for p44, and 50% for p62).
This work was supported in part by an MRC programme grant and EU
contract QLG-CT-1999-00181 to ARL and by a Grant-in-Aid for Sci-
entific Research (KAKENH 15790596) from the Japan Society for the
Figure4
Mutation analysis and cellular responses. (a) Mutation analysis:
genomic DNA from XP1J1 and parents were amplified by PCR using
primers spanning the G47R mutation site. The PCR products were in-
cubated either without (lanes marked) or with MvaI (lanes markedþ )
and electrophoresed on an agarose gel. Lane 1: marker; lanes 2 and 3:
control (normal fibroblast genomic DNA), lanes 4 and 5: proband; lanes
6 and 7: father; lanes 8 and 9: mother; lane 10: marker. (b) Breaks
generated in cellular DNA. Cells embedded in agarose were irradiated
with the indicated doses of ultraviolet B and then incubated for 1 h in
the presence of hydroxyurea and ara-C. The length of the comet tail
moment was determined after lysis, electrophoresis, and staining with
ethidium bromide. (c) TFIIH levels: Steady-state levels of TFIIEa (white
columns) and of the cdk7 (dotted columns), p44 (dashed columns), and
p62 (black columns) subunits of TFIIH are expressed as percentages of
the amounts present in the healthy individual C3PV analyzed in parallel.
Means of two experiments are shown. XP, xeroderma pigmentosum.
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